Subscribe To Our Free Newsletter |
Orchid Pharma jumps after receiving USFDA nod for Exblifep injections
Orchid Pharma rallied 5.76% to Rs 1,217.20 after the company has received an approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Exblifep(Cefepime and Enmetazobactam injections).